Genomics BioSci & Tech. Statistics

Total Valuation

TPEX:4195 has a market cap or net worth of TWD 2.16 billion. The enterprise value is 2.68 billion.

Market Cap	2.16B
Enterprise Value	2.68B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4195 has 72.45 million shares outstanding.

Current Share Class	72.45M
Shares Outstanding	72.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.74%
Owned by Institutions (%)	4.58%
Float	53.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.04
PB Ratio	3.70
P/TBV Ratio	4.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-68.03
EV / Sales	3.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.74

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.08.

Current Ratio	1.20
Quick Ratio	0.67
Debt / Equity	1.08
Debt / EBITDA	n/a
Debt / FCF	-3.92
Interest Coverage	-6.14

Financial Efficiency

Return on equity (ROE) is -11.06% and return on invested capital (ROIC) is -8.03%.

Return on Equity (ROE)	-11.06%
Return on Assets (ROA)	-3.78%
Return on Invested Capital (ROIC)	-8.03%
Return on Capital Employed (ROCE)	-9.43%
Weighted Average Cost of Capital (WACC)	3.90%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.51
Inventory Turnover	2.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.88% in the last 52 weeks. The beta is 0.05, so TPEX:4195's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	+62.88%
50-Day Moving Average	26.60
200-Day Moving Average	24.55
Relative Strength Index (RSI)	52.95
Average Volume (20 Days)	1,085,338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4195 had revenue of TWD 708.38 million and -39.43 million in losses. Loss per share was -0.54.

Revenue	708.38M
Gross Profit	231.36M
Operating Income	-84.16M
Pretax Income	-67.63M
Net Income	-39.43M
EBITDA	-20.73M
EBIT	-84.16M
Loss Per Share	-0.54

Full Income Statement

Balance Sheet

The company has 172.90 million in cash and 628.25 million in debt, giving a net cash position of -455.35 million or -6.29 per share.

Cash & Cash Equivalents	172.90M
Total Debt	628.25M
Net Cash	-455.35M
Net Cash Per Share	-6.29
Equity (Book Value)	582.07M
Book Value Per Share	7.04
Working Capital	106.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -86.79 million and capital expenditures -73.49 million, giving a free cash flow of -160.28 million.

Operating Cash Flow	-86.79M
Capital Expenditures	-73.49M
Depreciation & Amortization	63.43M
Net Borrowing	111.75M
Free Cash Flow	-160.28M
FCF Per Share	-2.21

Full Cash Flow Statement

Margins

Gross margin is 32.66%, with operating and profit margins of -11.88% and -5.57%.

Gross Margin	32.66%
Operating Margin	-11.88%
Pretax Margin	-9.55%
Profit Margin	-5.57%
EBITDA Margin	-2.93%
EBIT Margin	-11.88%
FCF Margin	n/a

Dividends & Yields

TPEX:4195 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.83%
FCF Yield	-7.44%

Dividend Details

Stock Splits

The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Aug 8, 2023
Split Type	Forward
Split Ratio	1.02

Scores

TPEX:4195 has an Altman Z-Score of 1.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	3